Skip to main content

UNC and UNC Lineberger researchers and trainees will be presenting talks and participating in scientific and educational panels and discussions on the latest cancer research at the American Society of Clinical Oncology’s Annual Meeting in Chicago, May 31-June 4.

The largest clinical cancer research meeting in the world, ASCO attracts more than 40,000 attendees from around the world. This year’s meeting will feature more than 5,000 scientific abstracts.

The UNC Lineberger presentations include:

Friday, May 31

Rapid Oral Abstract Session

Breast Cancer—Local/Regional/Adjuvant

2:45 – 4:15 p.m. CT    |    E451

3:39 – 3:45 p.m.:  Recurrence score gene axes scores and outcomes by race and ethnicity in the RxPONDER trial. (Abstract: 515)

Yara Abdou, MD


Oral Abstract Session

Care Delivery and Quality Care

2:45 – 5:45 p.m. CT  |   S100A

4:45 – 4:57 p.m. CT: Implementing financial toxicity and health-related social risks screening and referral. (Abstract: 11006)

Bridgette Thom, PhD

Saturday, June 1

Poster Session

Developmental Therapeutics—Immunotherapy
9 a.m. – 12 p.m. CT    |    Hall A

A phase 1, first-in-human study of autologous monocytes engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants with HER2-overexpressing solid tumors. (Abstract: TPS2682 | Poster: 154b)

Yara Abdou, MD


Targeting a non-canonical STING signaling pathway in T cells to improve antitumor immunity. (Abstract: 2574 | Poster: 53)

Jeremy Meier, MD, PhD

Sunday, June 2

Poster Session

Head and Neck Cancer

9 a.m. – 12 p.m. CT    |    Hall A

Early signs of efficacy in patients with anti-PD-1 naïve and anti-PD-1 resistant HNSCC treated with NBTXR3/SBRT in combination with nivolumab or pembrolizumab in the phase I trial Study 1100. (Abstract: 6035 | Poster: 338)

Colette Shen, MD, PhD

Monday, June 3

Poster Session

Quality Care/Health Services Research
9 a.m. – 12 p.m. CT    |    Hall A

Association of frailty assessed by a ten-item frailty index (FI-CGA-10) with health-related quality of life in older adults with cancer. (Abstract: 11047 | Poster: 242)

Hyman Muss, MD, FASCO  


Implementation and preliminary efficacy of a risk stratification system +/- patient-reported outcomes monitoring for patients with hospital-diagnosed advanced lung cancer. (Abstract: 11095 Poster: 290)

Emily Ray, MD, MPH


Clinical Science Symposium

Use of MRD-Guided Strategies to Optimize Therapeutic Interventions

9:45 – 11:15 a.m. CT | Hall D1


Patient Perspectives

9:57 a.m. CT: Patricia Spears, FASCO


Panel Discussion

11:01 – 11:15 a.m. CT

Discussant: Patricia Spears, FASCO


Oral Abstracts Session

Pediatric Oncology II

11:30 a.m. – 2:30 p.m. CT    |    S504

1:06 – 1:18 p.m. CT: Sequencing: This Is What You Came For

Discussant: Adam Palmer, PhD


Panel Discussion

Publication 101 – Peer Review & Becoming a Successful Author

12 – 12:45 p.m. CT   |   Hall C

Panelist: Yara Abdou, MD


Poster Session

Lung Cancer—Non-Small Cell Metastatic

1:30 – 4:30 p.m. CT    |    Hall A 

Efficacy of immunotherapy retreatment in patients with non-small cell lung cancer receiving consolidative durvalumab.  (Abstract: 8625 | Poster: 489)

Allison Carroll, PharmD


Oral Abstracts Session

Breast Cancer—Local/Regional/Adjuvant

3 – 6 p.m. CT    |    Hall B1

4:36 p.m. CT: Treatment and Outcomes in Select Subpopulations With Breast Cancer

Discussant: Lisa A. Carey, MD, ScM, FASCO